Jeffrey S. Mathiesen is CFO at Gemphire Therapeutics Inc. (GEMP). They have made 1 open-market trade across 1 company since 2016, most recently 2020-06-15.
CIK 0001638287
1 open-market purchase totalling $40K since 2016, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GEMP | BUY | 2016-08-10 | 2016-08-12 | $10.00 | $40K | +4.7% | +26.3% | -3.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.